MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
TBPH
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Theravance Biopharma (TBPH) Ownership - Who owns Theravance Biopharma?

Theravance Biopharma Inc is a biopharmaceutical company focused on the development and commercialization of medicines to improve patients lives... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Pharmaceuticals Other
Address
Ugland House, South Church Street
Phone
+1 650 808-6000
Employees
99
Web
https://www.theravance.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
854.23M
P/E Ratio
7.43
Total Cash
394.67M
Projected Growth
N/A
Total Debt
40.5M
Revenue
109.78M
Risk (Beta)
0.51
Dividend Yield
N/A
Total Cash/Share
7.66
Total Debt/Equity
N/A
Revenue/Share
2.12 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
TBPH
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for TBPH
A.I. Advisor
published General Information

General Information

a developer of small molecule pharmaceutical products

Industry Biotechnology

Profile
Details
Industry
Pharmaceuticals Other
Address
Ugland House, South Church Street
Phone
+1 650 808-6000
Employees
99
Web
https://www.theravance.com